-       Report 
- October 2025
-  190 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
          -       Report 
- October 2025
-  270 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- April 2025
-  85 Pages 
- Global 
   From       €3500EUR$4,192USD£3,186GBP 
            -       Report 
- August 2025
-  120 Pages 
- Global 
   From       €3687EUR$4,123USD£3,244GBP 
      €4338EUR$4,850USD£3,816GBP 
            -       Report 
- October 2025
-  195 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
             -       Report 
- October 2025
-  189 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
            -       Report 
- August 2025
-  195 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
          -       Report 
- October 2025
-  250 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- May 2025
-  200 Pages 
- Europe 
   From       €2227EUR$2,490USD£1,959GBP 
          -       Report 
- September 2024
-  100 Pages 
- Global 
   From       €5322EUR$5,950USD£4,681GBP 
          -       Report 
- September 2024
-  100 Pages 
- Global 
   From       €5322EUR$5,950USD£4,681GBP 
          -       Report 
- October 2024
-  139 Pages 
- Global 
   From       €2236EUR$2,500USD£1,967GBP 
          -       Report 
- March 2024
-  200 Pages 
- Global 
   From       €3712EUR$4,150USD£3,265GBP 
          -       Report 
- July 2023
-  145 Pages 
- Global 
   From       €2818EUR$3,150USD£2,478GBP 
          -       Report 
- December 2022
- Global 
        €4249EUR$4,750USD£3,737GBP 
          -       Report 
- May 2023
-  78 Pages 
- Global 
   From       €3500EUR$4,192USD£3,186GBP 
       
      The Automated Breast Ultrasound System (ABUS) is a technology used in women's health to detect breast cancer. It is a non-invasive imaging technique that uses sound waves to create a three-dimensional image of the breast. This technology is used to supplement traditional mammography, which is the gold standard for breast cancer screening. ABUS is particularly useful for women with dense breast tissue, as it can detect smaller lesions that may be missed by mammography. It is also beneficial for women    who are at high risk for breast cancer, as it can detect cancer at an earlier stage.
The ABUS market is growing rapidly, driven by increasing awareness of the importance of early detection of breast cancer and the need for improved screening methods. The market is expected to continue to grow in the coming years, driven by technological advancements and increasing demand for improved breast cancer screening.
Some of the major companies in the ABUS market include GE Healthcare, Siemens Healthineers, Hologic, FUJIFILM SonoSite, and Philips Healthcare. Show Less   Read more